Dr. Zhihong Zhang 张志红
Chief Physician, Associate Professor
Department of Respiratory Medicine, Anhui Provincial Cancer Hospital, Hefei
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of respiratory diseases, including asthma, COPD, lung cancer, interstitial lung disease, pulmonary embolism, and pleural disorders.
Dr. Zhang is Chief Physician and Associate Professor at Anhui Provincial Cancer Hospital. Completed a postdoctoral fellowship at the University of Tennessee Medical Center (2015–2018) and training in lung cancer interventional therapy at Ruhrlandklinik, Germany (2011). Expertise includes bronchoscopic valve implantation, lung biopsy, and mechanical ventilation. Has led or participated in multiple national and provincial research projects.
Professional roles
- Member, Young and Middle-aged Working Committee, Respiratory Physician Branch, Chinese Medical Doctor Association
Name order: in Chinese the family name comes first (Zhang Zhihong). Papers usually list the name as Zhihong Zhang or Zhang Z.
Selected publications
32 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- MedComm (2020), 2026 (senior author): Integrated Genomic, Transcriptomic, and Circulating Biomarkers Predict Benefit to Immune Checkpoint Inhibitor Plus Chemotherapy in Advanced Non-Small Cell Lung Cancer. PubMed 42415854
- Int J Gen Med, 2024 (senior author): Comprehensive Analysis of circRNA-Related mRNAs as Prognostic Factors in Non-Smoking Women with Lung Adenocarcinoma. PubMed 39650787
- Asia Pac J Clin Oncol, 2023 (senior author): Real-world data on efficacy and safety of osimertinib in non-small cell lung cancer patients with EGFR T790M mutation detected by first and repeat rebiopsy. PubMed 36756895
- Medicine (Baltimore), 2021 (senior author): Exploration of genes and tumor infiltrating lymphocytes in female lung adenocarcinoma microenvironment that predicted prognosis. PubMed 34941080
- Medicine (Baltimore), 2021 (senior author): Exploration of immune-related cells and ceRNA in squamous cell lung cancer. PubMed 34477137
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion